Anakinra - Swedish Orphan Biovitrum
At a glance
- Drug Originator Amgen
- Drug Licenced by Aventis Combinatorial Technologies Center; Dongbao; Savient Pharmaceuticals; Swedish Orphan Biovitrum; University of Colorado Foundation
- Drug Class Anti-infectives; Anti-inflammatories; Antibacterials; Antigouts; Antineoplastics; Antirheumatics; Recombinant proteins
- Mechanism of Action Interleukin 1 receptor antagonists
- USA Patent Applicants BIOVITRUM AB
- USA Patents 155
- BLAs 1
- International Patents 2,435
Disclaimer